Consultations on compound monograph documents
51 consultations on documents of this type.
Consultations
-
Consultation on the draft monograph for SS-31 (elamipretide), which the assessment committee released for public comment before ratification. The draft grades the compound's principal assessed outcome at moderate certainty and states the…
16 submissions4 not accepted -
Consultation on the draft monograph for CJC-1295, which the assessment committee released for public comment before ratification. The draft grades the compound's principal assessed outcome at low certainty and states the basis for that…
13 submissions -
Consultation on the draft monograph for amycretin, a co-agonist at the glucagon-like peptide-1 and amylin receptors. The draft grades the principal assessed outcome at low certainty on the basis of early-phase evidence, and records that no…
16 submissions1 not accepted -
Consultation on the draft monograph for Exenatide, which the assessment committee released for public comment before ratification. The draft grades the compound's principal assessed outcome at high certainty and states the basis for that…
8 submissions2 not accepted -
Consultation on the draft monograph for orforglipron, an oral non-peptide glucagon-like peptide-1 receptor agonist. The draft assesses a compound whose phase 3 programme was reporting during the consultation window, and grades the…
10 submissions2 not accepted -
Consultation on the draft monograph for Sermorelin, which the assessment committee released for public comment before ratification. The draft grades the compound's principal assessed outcome at low certainty and states the basis for that…
9 submissions -
Consultation on the draft monograph for KPV, which the assessment committee released for public comment before ratification. The draft grades the compound's principal assessed outcome at very low certainty and states the basis for that…
15 submissions1 not accepted -
Consultation on the draft monograph for PT-141 (bremelanotide), which the assessment committee released for public comment before ratification. The draft grades the compound's principal assessed outcome at moderate certainty and states the…
17 submissions1 not accepted -
Consultation on the draft monograph for Pramlintide, which the assessment committee released for public comment before ratification. The draft grades the compound's principal assessed outcome at moderate certainty and states the basis for…
15 submissions2 not accepted -
Consultation on the draft monograph for MOTS-c, which the assessment committee released for public comment before ratification. The draft grades the compound's principal assessed outcome at very low certainty and states the basis for that…
8 submissions1 not accepted -
Consultation on the draft monograph for Lixisenatide, which the assessment committee released for public comment before ratification. The draft grades the compound's principal assessed outcome at moderate certainty and states the basis for…
10 submissions1 not accepted -
Consultation on the draft monograph for 5-amino-1MQ, which the assessment committee released for public comment before ratification. The draft grades the compound's principal assessed outcome at very low certainty and states the basis for…
6 submissions1 not accepted -
Consultation on the draft monograph for Thymosin beta-4, which the assessment committee released for public comment before ratification. The draft grades the compound's principal assessed outcome at low certainty and states the basis for…
15 submissions1 not accepted -
Consultation on the draft monograph for retatrutide, a triple agonist at the glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon receptors. The principal assessed outcome is graded at low certainty because…
14 submissions3 not accepted -
Consultation on the draft monograph for Ecnoglutide, which the assessment committee released for public comment before ratification. The draft grades the compound's principal assessed outcome at low certainty and states the basis for that…
7 submissions1 not accepted -
Consultation on the draft monograph for Melanotan-II, which the assessment committee released for public comment before ratification. The draft grades the compound's principal assessed outcome at very low certainty and states the basis for…
4 submissions1 not accepted -
Consultation on the draft monograph for Epithalon, which the assessment committee released for public comment before ratification. The draft grades the compound's principal assessed outcome at very low certainty and states the basis for…
5 submissions1 not accepted -
Consultation on the draft monograph for Mazdutide, which the assessment committee released for public comment before ratification. The draft grades the compound's principal assessed outcome at moderate certainty and states the basis for…
9 submissions1 not accepted -
Consultation on the draft monograph for Ipamorelin, which the assessment committee released for public comment before ratification. The draft grades the compound's principal assessed outcome at low certainty and states the basis for that…
10 submissions1 not accepted -
Consultation on the draft monograph for CagriSema (cagrilintide with semaglutide), which the assessment committee released for public comment before ratification. The draft grades the compound's principal assessed outcome at moderate…
5 submissions1 not accepted
page 1 of 3